Collplant Biotechnologies Ltd
CLGN2.280USD
-0.011-0.46%
Market hours （ET）Quotes delayed by 15 min
26.12MMarket Cap
LossP/E TTM
More Details of Collplant Biotechnologies Ltd Company
CollPlant Biotechnologies Ltd, formerly known as Collplant Holdings Ltd, is a company dealing in aesthetic medicine and regenerative medicine based in Israel. The company provides products and technologies for broadly understood regenerative medicine, including tissue regeneration and organ production. The technology is based on plants and is based on the production of collagen type I (rhCollagen).
Company Info
Ticker SymbolCLGN
Company nameCollplant Biotechnologies Ltd
IPO dateSep 01, 1993
CEOMr. Eran Rotem, CPA
Number of employees57
Security typeOrdinary Share
Fiscal year-endSep 01
Address4 Oppenheimer Street
CityREHOVOT
Stock exchangeNASDAQ Global Market Consolidated
CountryIsrael
Postal code7670104
Phone972732325600
Websitehttps://www.collplant.com
Ticker SymbolCLGN
IPO dateSep 01, 1993
CEOMr. Eran Rotem, CPA
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Yehiel Tal
Mr. Yehiel Tal
Chief Executive Officer
Chief Executive Officer
31.14K
--
Dr. Philippe David Bensimon
Dr. Philippe David Bensimon
Vice President - Regulatory Affairs and Quality Assurance
Vice President - Regulatory Affairs and Quality Assurance
2.00K
--
Dr. Nadav Orr
Dr. Nadav Orr
Vice President - Research & Development
Vice President - Research & Development
--
--
Dr. Elan Penn, Ph.D.
Dr. Elan Penn, Ph.D.
Independent Director
Independent Director
--
--
Dr. Roger J. Pomerantz, M.D.
Dr. Roger J. Pomerantz, M.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Oded Shoseyov, Ph.D.
Dr. Oded Shoseyov, Ph.D.
Founder, Chief Scientist
Founder, Chief Scientist
--
--
Dr. Gili Hart
Dr. Gili Hart
Independent Director
Independent Director
--
--
Mr. Joseph Zarzewsky
Mr. Joseph Zarzewsky
Independent Director
Independent Director
--
--
Mr. Eran Rotem, CPA
Mr. Eran Rotem, CPA
Deputy Chief Executive Officer, Chief Financial Officer
Deputy Chief Executive Officer, Chief Financial Officer
--
--
Dr. Abraham (Avri) Havron, Ph.D.
Dr. Abraham (Avri) Havron, Ph.D.
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Yehiel Tal
Mr. Yehiel Tal
Chief Executive Officer
Chief Executive Officer
31.14K
--
Dr. Philippe David Bensimon
Dr. Philippe David Bensimon
Vice President - Regulatory Affairs and Quality Assurance
Vice President - Regulatory Affairs and Quality Assurance
2.00K
--
Dr. Nadav Orr
Dr. Nadav Orr
Vice President - Research & Development
Vice President - Research & Development
--
--
Dr. Elan Penn, Ph.D.
Dr. Elan Penn, Ph.D.
Independent Director
Independent Director
--
--
Dr. Roger J. Pomerantz, M.D.
Dr. Roger J. Pomerantz, M.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Oded Shoseyov, Ph.D.
Dr. Oded Shoseyov, Ph.D.
Founder, Chief Scientist
Founder, Chief Scientist
--
--
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2024
FY2024Q2
FY2023
FY2023Q2
FY2022
FY2022Q2
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Revenues from the sales of goods
515.00K
0.00%
By RegionUSD
Name
Revenue
Proportion
United States
484.00K
93.98%
Israel
31.00K
6.02%
Europe
0.00
0.00%
Canada
0.00
0.00%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Revenues from the sales of goods
515.00K
0.00%
Shareholding Stats
Updated: Sat, May 17
Updated: Sat, May 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Sagy (Ami)
15.28%
Loewenbaum (George Walter)
8.97%
St. Denis J. Villere & Company, LLC
4.30%
Pinnacle Associates Ltd.
3.85%
Evans (Hugh M)
2.97%
Other
64.63%
Shareholders
Shareholders
Proportion
Sagy (Ami)
15.28%
Loewenbaum (George Walter)
8.97%
St. Denis J. Villere & Company, LLC
4.30%
Pinnacle Associates Ltd.
3.85%
Evans (Hugh M)
2.97%
Other
64.63%
Shareholder Types
Shareholders
Proportion
Individual Investor
29.91%
Investment Advisor
7.11%
Investment Advisor/Hedge Fund
4.77%
Hedge Fund
1.06%
Family Office
0.13%
Research Firm
0.11%
Other
56.90%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
40
5.46M
42.96%
+129.16K
2025Q1
43
5.89M
47.00%
-12.15K
2024Q4
45
6.34M
55.34%
-153.24K
2024Q3
47
6.23M
54.37%
+33.99K
2024Q2
47
6.08M
53.11%
-244.01K
2024Q1
47
6.01M
52.48%
-307.66K
2023Q4
51
6.09M
53.32%
-149.24K
2023Q3
56
6.34M
55.87%
-109.84K
2023Q2
58
6.40M
56.58%
+145.86K
2023Q1
60
5.97M
52.82%
-340.05K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Sagy (Ami)
1.94M
15.28%
--
--
Mar 15, 2025
Loewenbaum (George Walter)
1.14M
8.97%
+86.46K
+8.20%
Dec 31, 2024
St. Denis J. Villere & Company, LLC
483.87K
3.81%
--
--
Mar 31, 2025
Pinnacle Associates Ltd.
489.19K
3.85%
-500.00
-0.10%
Mar 31, 2025
Evans (Hugh M)
377.43K
2.97%
-1.00
-0.00%
Mar 15, 2025
Roumell Asset Management, L.L.C.
276.43K
2.17%
-38.86K
-12.32%
Jun 30, 2024
Loewenbaum (Lilian Shaw)
275.74K
2.17%
+70.09K
+34.08%
Dec 31, 2024
AMH Equity, Ltd.
125.00K
0.98%
+8.50K
+7.30%
Mar 31, 2025
Brown Advisory
111.20K
0.87%
-8.27K
-6.92%
Mar 31, 2025
Benjamin F. Edwards & Company, Inc.
39.76K
0.31%
-10.69K
-21.19%
Jun 30, 2024
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
